HEALTHGEN BIOTECH
68876533.803.17% ( +1.04 )
HEALTHGEN BIOTECH (688765)
Wuhan Healthgen Biotechnology Corp. engages in the research and development of molecular pharmaceuticals in China. The company offers recombinant human serum al...
- Open
- 33.20
- High
- 34.18
- Low
- 33.20
- Prev. Close
- 32.76
- Volume
- 42.69K
- Turnover
- 144.19M
- Avg Price
- 33.78
- Bid/Ask Ratio
- 14.89%
- Amplitude
- 2.99%
- 52wk High
- 132.03
- Volume Ratio
- 1.39
- Turnover Ratio
- 5.93%
News
- Zhitong · Oct 27, 2025 at 08:40 PM
The Sci-Tech Innovation Board's Sci-Tech Growth Tier "welcomes" HeYuan Biotechnology, Xi'an YiCai, BeBetter, and others, all of which saw significant gains on their first day of listing
- Zhitong · Oct 27, 2025 at 08:30 PM
Four new stocks in the A-share market were listed for the first time, setting a new high for the number of listings in a single day this year
- Zhitong · Oct 26, 2025 at 03:09 AM
The first batch of 3 new stocks from the Sci-Tech Innovation Growth Sector will be listed on October 28
- Zhitong · Oct 23, 2025 at 08:52 AM
On October 28th, Healthgen Biotechnology will be listed and will be included in the Sci-Tech Innovation Growth Tier from the date of listing
- Zhitong · Oct 22, 2025 at 06:17 PM
New regulations for institutions participating in IPOs of unprofitable companies take effect — "high" lock-up = "high" allocation
- Zhitong · Oct 13, 2025 at 05:35 PM
A-share subscription | Healthgen Biotechnology opens subscription with a total of 8 drugs in the pipeline
